<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="355">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04335188</url>
  </required_header>
  <id_info>
    <org_study_id>COVID-19 Registry</org_study_id>
    <nct_id>NCT04335188</nct_id>
  </id_info>
  <brief_title>COVID-19 Registry Rhineland-Palatinate (Germany)</brief_title>
  <official_title>COVID-19 Registry Rhineland-Palatinate (Germany) - COVID-19 Disease Registry a National, Multicentre, Non-interventional, Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IHF GmbH - Institut f端r Herzinfarktforschung</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministerium f端r Soziales, Arbeit, Gesundheit und Demografie des Landes Rheinland-Pfalz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IHF GmbH - Institut f端r Herzinfarktforschung</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Documentation of all patients undergoing inpatient treatment for SARS-CoV-2 infection with
      regard to clinical status at admission, medical history, inpatient treatment and course of
      disease. The aim is to create a risk stratification of the infection on the basis of clinical
      data as well as therapy and disease progression of the patients. This may also contribute to
      a better planning of resources.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 6, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Chest x-ray</measure>
    <time_frame>throughout study completion, in average 1.5 years</time_frame>
    <description>presence of infiltrates</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Chest CT</measure>
    <time_frame>throughout study completion, in average 1.5 years</time_frame>
    <description>presence of infiltrates</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Supportive care - ICU</measure>
    <time_frame>throughout study completion, in average 1.5 years</time_frame>
    <description>number of patients with ICU treatment required</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Supportive care - oxygen therapy</measure>
    <time_frame>throughout study completion, in average 1.5 years</time_frame>
    <description>number of patients with oxygen therapy required</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Supportive care - ventilation</measure>
    <time_frame>throughout study completion, in average 1.5 years</time_frame>
    <description>number of patients with ventilation required</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Medication</measure>
    <time_frame>throughout study completion, in average 1.5 years</time_frame>
    <description>number of patients with medication changes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Therapeutic strategies</measure>
    <time_frame>throughout study completion, in average 1.5 years</time_frame>
    <description>number of patients with ECMO required</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lab parameters</measure>
    <time_frame>throughout study completion, in average 1.5 years</time_frame>
    <description>number of patients with significant changes in lab parameters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intra-hospital complications</measure>
    <time_frame>throughout study completion, in average 1.5 years</time_frame>
    <description>number of patients with complications during hospital stay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vital status at discharge</measure>
    <time_frame>throughout study completion, in average 1.5 years</time_frame>
    <description>vital status at discharge: alive, dead</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>COVID</condition>
  <arm_group>
    <arm_group_label>In-patients with SARS-CoV-2 infection</arm_group_label>
    <description>In-patients fulfilling the following criteria:
SARS-CoV-2 infection In-patient treatment Written informed consent for participation in observational study No explicit medical exclusion criteria are stated to avoid selection bias.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prospective oberservational registry</intervention_name>
    <description>Non interventional study.</description>
    <arm_group_label>In-patients with SARS-CoV-2 infection</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        About 110 hospitals in Rhineland-Palatinate (Germany) treating patients with SARS-CoV-2
        infection.

        All stationary treated patients with SARS-CoV-2 infection will be included.

        Preferably all hospitals in Rhineland-Palatinate, Germany, treating patients with
        SARS-CoV-2 infection.

        Consecutive enrolment of all patients fulfilling the patient selection criteria to avoid
        selection bias.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  In-patients fulfilling the following criteria:

        SARS-CoV-2 infection In-patient treatment Written informed consent for participation in
        observational study

        Exclusion Criteria:

          -  No explicit medical exclusion criteria are stated to avoid selection bias.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anselm Gitt, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Stiftung IHF and Klinikum der Stadt Ludwigshafen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anselm Gitt, MD</last_name>
    <phone>+49 621 5032944</phone>
    <email>gitta@klilu.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sebastian Diebold, PhD</last_name>
    <phone>+4962159577214</phone>
    <email>diebold@ihf.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinikum der Stadt Ludwigshafen am Rhein GmbH, Klinik f端r Herzchirurgie</name>
      <address>
        <city>Ludwigshafen</city>
        <state>RLP</state>
        <zip>67063</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anselm Gitt, MD</last_name>
      <phone>0621 - 5032944</phone>
      <email>gitta@klilu.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 31, 2020</study_first_submitted>
  <study_first_submitted_qc>April 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2020</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

